STOCK TITAN

Ceribell (NASDAQ: CBLL) CEO sells 39,000 shares after options exercise

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Ceribell, Inc. President and CEO Xingjuan Chao reported an exercise-and-sell transaction in Ceribell common stock. On May 5, 2026, she exercised stock options to acquire 25,000 shares at a conversion price of $4.70 per share and sold 39,000 shares in open-market trades at prices ranging from $19.77 to $20.48, based on weighted average prices. These trades were executed under a pre-arranged Rule 10b5-1 trading plan. Following the transactions, she holds 836,347 shares directly and 369,088 shares indirectly through the ACP 2021 Trust, where she serves as co-trustee and disclaims beneficial ownership beyond her pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Chao Xingjuan
Role President and CEO
Sold 39,000 shs ($784K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 1,446 $0.00 --
Exercise Stock Option (Right to Buy) 23,554 $0.00 --
Sale Common Stock 14,000 $20.12 $282K
Exercise Common Stock 1,446 $4.70 $7K
Sale Common Stock 1,446 $20.12 $29K
Exercise Common Stock 23,554 $4.70 $111K
Sale Common Stock 23,554 $20.09 $473K
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 291,602 shares (Direct, null); Common Stock — 836,347 shares (Direct, null); Common Stock — 369,088 shares (Indirect, By ACP 2021 Trust)
Footnotes (1)
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.77 to $20.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The stock option is fully vested and currently exercisable.
Shares sold 39,000 shares Open-market sales on May 5, 2026
Sale price range $19.77–$20.48 per share Prices for reported open-market sales
Options exercised 25,000 shares Stock options exercised on May 5, 2026
Option exercise price $4.70 per share Conversion price for exercised stock options
Direct holdings after transactions 836,347 shares Common stock directly held post-transaction
Indirect trust holdings 369,088 shares Common stock held by ACP 2021 Trust
Option expiration February 16, 2033 Expiration date for referenced stock option
Rule 10b5-1 trading plan financial
"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
beneficial ownership financial
"therefore may be deemed to share beneficial ownership of these securities."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chao Xingjuan

(Last)(First)(Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CALIFORNIA 94085

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/05/2026S(1)14,000D$20.12(2)836,347D
Common Stock05/05/2026M(1)1,446A$4.7837,793D
Common Stock05/05/2026S(1)1,446D$20.12(2)836,347D
Common Stock05/05/2026M(1)23,554A$4.7859,901D
Common Stock05/05/2026S(1)23,554D$20.09(2)836,347D
Common Stock369,088IBy ACP 2021 Trust(3)(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$4.705/05/2026M(1)1,446 (5)02/16/2033Common Stock1,446$0291,602D
Stock Option (Right to Buy)$4.705/05/2026M(1)23,554 (6)02/16/2033Common Stock23,554$0125,031D
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.77 to $20.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
3. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
4. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
5. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
6. The stock option is fully vested and currently exercisable.
/s/ Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Ceribell (CBLL) CEO Xingjuan Chao report?

Ceribell CEO Xingjuan Chao reported exercising options for 25,000 shares at $4.70 and selling 39,000 common shares in open-market transactions. The sales occurred at prices between $19.77 and $20.48 per share under a pre-arranged Rule 10b5-1 trading plan.

At what prices did the Ceribell (CBLL) CEO sell company shares?

The reported Ceribell share sales used weighted average prices, with individual trades executed between $19.77 and $20.48 per share. The Form 4 notes the CEO can provide full trade details, including exact share counts at each separate price within this disclosed range.

How many Ceribell (CBLL) shares does the CEO hold after these transactions?

After the May 5, 2026 transactions, the CEO directly holds 836,347 Ceribell common shares. She is also co-trustee of the ACP 2021 Trust, which holds 369,088 additional shares, and she disclaims beneficial ownership except to the extent of her pecuniary interest in those trust-held shares.

Were the Ceribell (CBLL) CEO’s stock sales made under a Rule 10b5-1 plan?

Yes. The Form 4 explicitly states that all reported transactions were effected under a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-schedule trades, which can indicate the timing of sales was set in advance rather than decided opportunistically.

What stock options did the Ceribell (CBLL) CEO exercise in this Form 4?

The CEO exercised stock options covering 25,000 Ceribell shares at a conversion price of $4.70 per share. The options are described as fully vested and currently exercisable, with vesting originally tied to monthly anniversaries of April 1, 2023, under the company’s option arrangement.

What is the vesting schedule disclosed for the Ceribell (CBLL) CEO’s options?

The Form 4 notes the option vests for 1/48 of the underlying shares on each monthly anniversary of April 1, 2023, contingent on continued employment or service. A footnote adds that the stock option referenced in this filing is now fully vested and currently exercisable by the reporting person.